Ireland - English - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - terbinafine hydrochloride - tablet - 250 milligram(s) - antifungals for systemic use; terbinafine

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - tolnaftate, quantity: 0.89 mg/g - spray, pressurised - excipient ingredients: butane; ppg-12-buteth-16; propane; isobutane; butylated hydroxytoluene; purified talc; ethanol - indicated for the topical treatment of skin infections due to common pathogenic fungi, including trichophyton rubrum, trichophyton mentagrophytes (t.gypseum), trichophyton tonsurans and epidermophyton floccosum. tinaderm powder and powder spray are recommended for adjunctive use with tinaderm cream or solution in fungal infections of interiginous and other naturally moist skin areas in which drying may enhance the therapeutic response. tinaderm powder and powder spray may also be used alone in simple cases of mild infection that respond to treatment with an antifungal powder and measures that promote skin hygiene.,following complete remission, tinaderm powder and powder spray alone may be continued to maintain remission or reduce the risk of reinfection.

Australia - English - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - tolnaftate, quantity: 10 mg/g - powder, dusting - excipient ingredients: silicon dioxide; purified talc - topical treatment of skin infections due to common pathogenic fungi, including trichophyton rubrum, trichophyton mentaggrophyton (t.gypseum), trichophyton tonsurans and epidermophyton floccosum. tinaderm powder is recommended for adjunctive use with tinaderm cream or solution in fungal infections of intertriginous and other naturally moist skin areas in which drying may enhance the therapeutic response. tinaderm powder may also be used alone in simple cases of mild infection that respond to treatment with antifungal powder and measures that promote skin hygiene. following complete remission, tinaderm powder alone may be contineud to maintain or reduce the risk of infection.

United States - English - NLM (National Library of Medicine)

genpak solutions, llc - triamcinolone acetonide (unii: f446c597ka) (triamcinolone acetonide - unii:f446c597ka) - triamcinolone acetonide cream 0.025% and 0.1% are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparations. pediatric patients may demonstrate greater susceptibility to topical corticosteroid-induced hpa axis suppression and cushing's syndrome than mature patients because of a larger skin surface area to body weight ratio. hpa axis suppression, cushing's syndrome, and intracranial hypertension have been reported in children receiving topical corticosteroids. manifestations of adrenal suppression in children include linear growth retardation, delayed weight gain, low plasma cortisol levels, and absence of response to acth stimulation. manifestations of intracranial hypertension include bulging fontanelles, headaches, and bilateral papilledema. administration of topical corticosteroids to children should be limited t